Actas espanolas de psiquiatria
August 1, 2024
Xiaoqi Qian, Jianjian Zhang
7 citations
A systematic review and meta-analysis of 14 randomized controlled trials involving 1,030 patients with inflammatory bowel disease found that mindfulness-based interventions reduce anxiety and depression and improve quality of life in the short term. Anxiety scores decreased significantly in the intervention group compared to controls, depression scores also dropped, and quality-of-life scores improved. The authors note that long-term effects remain uncertain and require further trials.
Actas espanolas de psiquiatria
April 1, 2024
Xiumei Li, Wei Gao, Jie Yu et al.
5 citations
In chronic kidney disease (CKD) patients with mild-to-moderate depression, adding mindfulness-based stress reduction (MBSR) to conventional care improved mental health, sleep quality, and quality of life more than conventional care alone. After matching, 35 patients received MBSR plus conventional management and 35 received only conventional management. The MBSR group had lower depression and better sleep scores, and higher scores for psychological resilience, mindfulness, and overall quality of life. MBSR appears to benefit psychological well-being in this population.
Actas espanolas de psiquiatria
March 1, 2025
Jingjing Yan, Fenhua Wang, Xianghua Yu
3 citations
Mindfulness therapy reduces anxiety and depressive symptoms in breast cancer patients. A meta-analysis of 15 randomized controlled trials with 1,823 patients found that mindfulness interventions significantly lowered anxiety scores (mean difference -0.67) and depression scores (mean difference -2.26) compared to control conditions. The type of intervention (mindfulness-based stress reduction versus other mindfulness approaches) and duration (more or less than 8 weeks) had little effect on outcomes. Some publication bias was detected. The findings support using mindfulness-based interventions, excluding mindfulness-based cognitive therapy, to improve psychological well-being in breast cancer patients.
Actas espanolas de psiquiatria
December 1, 2025
Safiye Zeynep Tatlı, Murat İlhan Atagün
2 citations
Treatment-resistant depression (TRD) affects many people who do not get better with standard antidepressants. This review of studies from 2015 to 2025 finds that newer treatments such as ketamine, esketamine, psychedelics, and neuromodulation therapies like repetitive transcranial magnetic stimulation and magnetic seizure therapy show promise. Some patients with TRD may actually have a bipolar spectrum condition and respond better to mood stabilizers and antipsychotics. Using biomarkers and pharmacogenetics could help choose the right treatment for each person. A multidisciplinary, personalized approach is needed to improve outcomes for TRD.
Actas espanolas de psiquiatria
June 15, 2026
Xinrong Zheng, Qijun Zhang, Hesheng Zhuang
Patients with pneumonia-induced sepsis who received personalized nursing combined with Mindfulness-Based Stress Reduction (MBSR) showed greater reductions in anxiety and depression, and greater improvements in self-efficacy, quality of life, and self-care ability compared with those receiving routine nursing alone. The combined nursing group (68 patients) had significantly lower scores on the Hamilton Anxiety Scale and Hamilton Depression Scale, and significantly higher scores on measures of self-efficacy, quality of life, and self-care ability than the routine nursing group (59 patients). The findings suggest that integrating personalized nursing with MBSR may be a beneficial strategy for improving psychological and functional outcomes in this patient population.
Actas espanolas de psiquiatria
May 1, 2025
Zeyu Zheng, Jing Han
Mindfulness-based stress reduction (MBSR) therapy, added to usual care, improves psychological outcomes for nasopharyngeal carcinoma (NPC) patients with moderate depression. In a retrospective analysis of 131 patients, those receiving MBSR showed significantly greater improvements in depression, anxiety, perceived stress, quality of life, and mindfulness awareness after eight weeks compared to a control group. Patients in the MBSR group also reported higher treatment satisfaction, willingness to recommend the treatment, and perceived benefit. The findings suggest MBSR offers adjunctive therapeutic value for this population.